Get the Stockscreener App
10.57
0.75%
-0.08
After Hours:
10.57
Telix Pharmaceuticals Ltd Adr Stock (TLX) Forecast
The Telix Pharmaceuticals Ltd Adr (TLX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.12, representing a +14.66% increase from the current price of $10.57. The highest analyst price target is $13.81, and the lowest is $10.43.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TLX Price Target
Average 15.78
(+49.25% Upside)
Is Telix Pharmaceuticals Ltd Adr (TLX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.01 | Neutral |
| STOCH(9,6) | 47.62 | Neutral |
| STOCHRSI(14) | 11.49 | Buy |
| MACD(12,26) | -0.2074 | Sell |
| ADX(14) | 16.64 | Neutral |
| William %R | -88.49 | Buy |
| CCI(14) | -69.32 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.90
Sell
|
10.93
Sell
|
| MA20 |
11.18
Sell
|
11.12
Sell
|
| MA50 |
11.52
Sell
|
11.22
Sell
|
| MA100 |
10.92
Sell
|
10.94
Sell
|
| MA200 |
9.785
Buy
|
10.83
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, TLX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on TLX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.01 indicates that TLX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 47.62 indicates that TLX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.49 indicates that TLX is oversold. This suggests that TLX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.64 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -69.32 indicates that TLX is still oversold but not to an extreme extent.
Long-term TLX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Telix Pharmaceuticals Ltd Adr financial reports and earnings history, Telix Pharmaceuticals Ltd Adr (TLX) stock could reach $3.7774 by 2030, $9.5499 by 2040 and $26.12 by 2050. See the projected annual prices until 2050 of the Telix Pharmaceuticals Ltd Adr stock below:
- Telix Pharmaceuticals Ltd Adr (TLX) is expected to reach an average price of $2.2295 in 2035, with a high prediction of $3.3736 and a low estimate of $2.8895. This indicates an $-78.91% rise from the last recorded price of $10.57.
- Telix Pharmaceuticals Ltd Adr (TLX) stock is projected to chart a bullish course in 2040, with an average price target of $8.7962, representing an $-16.78% surge from its current level. The forecast ranges from a conservative $10.45 to a sky-high $9.5499.
- Our analysts predict Telix Pharmaceuticals Ltd Adr (TLX) to jump 118.44% by 2045, soaring from $23.38 to an average price of $23.09, potentially reaching $23.91. While $23.38 is the low estimate, the potential upside is significant.
- Telix Pharmaceuticals Ltd Adr (TLX) stock is expected to climb by 2050, reaching an average of $25.11, a $137.57% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.12 and $25.32, respectively, highlighting the market's uncertainty.
Telix Pharmaceuticals Ltd Adr Stock (TLX) Year by Year Forecast
Telix Pharmaceuticals Ltd Adr Stock (TLX) Price Forecast for 2026
The predicted value for Telix Pharmaceuticals Ltd Adr (TLX) in 2026 is set at an average of $10.11. Estimates vary from a peak of $13.95 to a trough of $6.28, indicating an -4.33% surge from the present price of $10.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $11.46 | $10.43 | $13.81 | +8.45% |
| December, 2026 | $12.69 | $9.9151 | $13.95 | +20.01% |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Telix Pharmaceuticals Ltd Adr (TLX) is $15.75, with a high forecast of $26.33 and a low forecast of $5.1802. This indicates an +49.05% increase from the last price of $10.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.14 | $12.69 | $15.12 | +24.29% |
| February, 2027 | $13.29 | $12.55 | $26.33 | +25.73% |
| March, 2027 | $12.69 | $9.6413 | $14.86 | +20.07% |
| April, 2027 | $14.78 | $12.17 | $16.06 | +39.87% |
| May, 2027 | $12.91 | $11.65 | $14.97 | +22.10% |
| June, 2027 | $12.25 | $11.97 | $14.64 | +15.88% |
| July, 2027 | $10.42 | $10.09 | $13.18 | -1.41% |
| August, 2027 | $8.753 | $6.773 | $10.52 | -17.19% |
| September, 2027 | $6.2951 | $5.2241 | $8.8636 | -40.44% |
| October, 2027 | $5.9271 | $5.8761 | $7.4056 | -43.92% |
| November, 2027 | $5.7497 | $5.5597 | $7.6566 | -45.60% |
| December, 2027 | $5.4818 | $5.1802 | $6.4833 | -48.14% |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Price Forecast for 2028
In 2028, Telix Pharmaceuticals Ltd Adr (TLX) is projected to reach an average price of $6.441, with a high projection of $10.03 and a low estimate of $2.8474. This indicates an -39.06% fall from the last price of $10.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0643 | $3.8843 | $5.3723 | -61.55% |
| February, 2028 | $3.6464 | $3.4164 | $4.9859 | -65.50% |
| March, 2028 | $4.1084 | $2.8474 | $4.4674 | -61.13% |
| April, 2028 | $6.2005 | $3.7989 | $6.2205 | -41.34% |
| May, 2028 | $7.683 | $5.631 | $8.142 | -27.31% |
| June, 2028 | $6.1951 | $6.1851 | $8.004 | -41.39% |
| July, 2028 | $7.4376 | $5.4361 | $7.8476 | -29.63% |
| August, 2028 | $7.2797 | $6.9897 | $9.0373 | -31.13% |
| September, 2028 | $8.6817 | $6.6307 | $9.1917 | -17.86% |
| October, 2028 | $8.2043 | $7.7038 | $9.3943 | -22.38% |
| November, 2028 | $7.5063 | $7.4063 | $10.03 | -28.98% |
| December, 2028 | $6.321 | $6.0609 | $8.3624 | -40.20% |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Price Forecast for 2029
The 2029 price forecast for Telix Pharmaceuticals Ltd Adr Stock (TLX) is $11.91 on average, with a high prediction of $22.30 and a low estimate of $1.5181. This represents an +12.65% increase from the previous price of $10.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.3261 | $6.2906 | $9.6651 | -30.69% |
| February, 2029 | $8.5902 | $5.8202 | $9.8502 | -18.73% |
| March, 2029 | $9.0843 | $8.6013 | $11.05 | -14.06% |
| April, 2029 | $9.7895 | $8.5384 | $22.30 | -7.38% |
| May, 2029 | $8.7336 | $5.6725 | $10.68 | -17.37% |
| June, 2029 | $10.87 | $8.2246 | $12.13 | +2.82% |
| July, 2029 | $9.0428 | $7.7547 | $11.06 | -14.45% |
| August, 2029 | $8.4269 | $8.1359 | $10.78 | -20.28% |
| September, 2029 | $6.641 | $6.311 | $9.381 | -37.17% |
| October, 2029 | $5.0261 | $3.0461 | $6.774 | -52.45% |
| November, 2029 | $2.6102 | $1.5181 | $5.1471 | -75.31% |
| December, 2029 | $3.5353 | $2.2053 | $4.0242 | -66.55% |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Price Forecast for 2030
Telix Pharmaceuticals Ltd Adr Stock (TLX) is expected to reach an average price of $3.1729 in 2030, with a high forecast of $6.3086 and a low forecast of $0.0373. This signifies an -69.98% decrease from the last price of $10.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.1594 | $1.9694 | $3.7774 | -79.57% |
| February, 2030 | $1.9335 | $1.6004 | $2.935 | -81.71% |
| March, 2030 | $0.6076 | $0.4566 | $1.8345 | -94.25% |
| April, 2030 | $0.1927 | $0.0373 | $1.5217 | -98.18% |
| May, 2030 | $0.6968 | $0.1332 | $1.0348 | -93.41% |
| June, 2030 | $2.8309 | $0.3979 | $2.8509 | -73.22% |
| July, 2030 | $4.366 | $2.272 | $4.804 | -58.69% |
| August, 2030 | $2.9201 | $2.9101 | $4.7081 | -72.37% |
| September, 2030 | $4.2153 | $2.1822 | $4.6253 | -60.12% |
| October, 2030 | $4.0994 | $3.8094 | $5.8464 | -61.22% |
| November, 2030 | $5.5435 | $3.4714 | $6.0535 | -47.55% |
| December, 2030 | $5.1186 | $4.6076 | $6.3086 | -51.57% |
10.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):